Weight Control

Food as medicine: Six insights from a 911�� nutrition expert

Heather Carroll — Mon, 17 Aug 2026 15:08:52 +0000

Food as medicine: Six insights from a 911�� nutrition expert Heather Carroll Mon, 08/17/2026 - 11:08

In This Story

Key Takeaways

911�� nutrition expert and registered dietitian Raedah Basiri shared six key lessons with Honors College students, emphasizing that personalized, gradual nutrition changes are often more effective than one-size-fits-all approaches to preventing and managing chronic disease.
Basiri highlighted the importance of nutrition in health care, noting that diet-based interventions, supported by technology and real-time feedback, can improve long-term health outcomes and encourage healthier behaviors.
She also stressed that nutrition support remains essential even when patients use weight-loss medications, and that building trust between patients and health care providers is critical.

911�� community health students share their insights from nutrition professor and registered dietitian Raedah Basiri for their Honors College project exploring nutrition interventions for chronic disease.

Community Health student Janay Hopgood

The concept of food as medicine is gaining traction as a way to prevent and manage chronic disease. During an Honors College consulting course (Honors 260), community health student Janay Hopgood and a teammate interviewed Raedeh Basiri, assistant professor of nutrition and a registered dietitian, to inform their approach.

Their project challenged them to develop an innovative solution to improve long-term health outcomes and prevent chronic disease among a health care organization partner.

"We aimed to integrate nutrition into health care by leveraging technology, community partnerships, and data-driven strategies to promote healthier lifestyles and advance health equity," Hopgood said. "Dr. Basiri helped us better understand which avenues of research and implementation were realistic, challenged common misconceptions, and provided thoughtful feedback. Most importantly, she created a space where we could openly discuss our developing concept and draw upon her knowledge and experience."

Here are six insights that Hopgood and her partner developed from their interview with Basiri:

Personalization matters.
Effective nutrition interventions start with collecting comprehensive data to understand the whole person, including their food access, finances, lifestyle, physical activity, and living environment. One-size-fits-all recommendations rarely work, Basiri said.
Start small.
Bombarding people with too much nutrition information at once isn't sustainable. Introducing small, personalized changes gradually is more likely to improve health outcomes.
Nutrition is too often overlooked in favor of medication.
Basiri highlighted a gap between nutrition research and clinical practice. When lifestyle changes don't produce immediate results, patients often get moved to medication despite strong evidence supporting the long-term benefits of dietary interventions.
Real-time feedback encourages behavior change.
Basiri said technology can help patients better understand how food affects their health, especially for those with limited access to a physician. Continuous glucose monitors provide real-time feedback that can increase compliance, while artificial intelligence tools can help deliver similar personalized guidance.
Weight-loss medications still need nutritional support.
Although GLP-1 medications are effective for weight loss, Basiri noted that they can also contribute to issues such as malnutrition, hair loss, and bone density loss. Nutrition support, she said, can help ensure patients don't "solve the problem and create another one."
Trust is the foundation of lasting impact.
Basiri emphasized that successful nutrition programs are built on trust, both between nutrition practitioners and patients, and between nutrition practitioners and other health care professionals. Positive outcomes are most likely to create that trust, leading to more referrals and greater demand for nutrition-based services.

Topics

CPH Student Research

Nutrition and Weight Management

Weight Control

College of Public Health

Research

Students

Honors College

911�� leads phase 2 clinical trial for pill to help maintain weight loss after GLP-1s

Taylor Thomas — Fri, 09 Jan 2026 15:52:49 +0000

911�� leads phase 2 clinical trial for pill to help maintain weight loss after GLP-1s Taylor Thomas Fri, 01/09/2026 - 10:52

GLP-1 medications like Ozempic and Wegovy have transformed obesity treatment, but maintaining weight loss after the medications stop remains a challenge. 911�� is leading a new clinical trial that may help people sustain their results.

The university is one of six research sites across the United States administering a Phase 2 clinical trial of ARD-201, a novel weight-maintenance drug developed by Aardvark Therapeutics that works differently from existing obesity medications. Unlike injectable medications that drive significant short-term weight loss, ARD-201 is being studied for its potential role in appetite regulation and weight maintenance after injectable therapy ends. The oral medication works by activating the bitter taste receptors in the gut and brain without creating an actual bitter taste, signaling the body to eat less.

Lawrence Cheskin. Photo by Emma Anderson.

“It’s almost a survival instinct,” said Lawrence Cheskin, obesity researcher, professor, and past chair of the Department of Nutrition and Food Studies, which is leading the 911�� research site for the trial. “When something tastes bitter, the body assumes there may be a toxin, so you back off.”

By subtly triggering that signal, the drug appears to reduce appetite without the dramatic effects associated with injectable medications. “This isn’t going to cause large weight loss on its own,” Cheskin said. “The question is whether it can help people keep weight off.”

The trial will enroll adults who previously lost weight using injectable medications and have since stopped them. Researchers will track how much weight participants regain over time and compare outcomes with published data showing typical patterns of weight regain after injectables are ceased. The study is an open-label Phase 2 trial, meaning participants know they are receiving the drug, and there is no placebo comparison group.

Earlier research helped lay the groundwork for the current study. A closely related compound, ARD-101, was previously tested for treating Prader-Willi syndrome, a rare genetic condition marked by extreme, chronic hunger. ARD-201 is now under investigation as an oral therapy for broader obesity and weight-management use.

911�� was selected as a trial site based on its longstanding expertise in obesity research and clinical weight management, according to Cheskin. If results from this Phase 2 study are promising, they could inform larger, randomized trials to more rigorously test the drug’s effectiveness for long-term weight maintenance.

Thumbnail photo by David Trinks via Unsplash.

Learn more about 911��'s Grand Challenge Initiative

Learn more about Research at 911��

In This Story

Lawrence J. Cheskin, MD

Topics

Weight Control

Obesity

Clinical Trials

College of Public Health

GCI-Grand Challenge Initiative

South Florida Reporter: Dr. Sapna Batheja comments on the limitations of research in an article on the weight loss method of front-loading calories

eander6 — Tue, 13 Sep 2022 15:59:05 +0000

South Florida Reporter: Dr. Sapna Batheja comments on the limitations of research in an article on the weight loss method of front-loading calories eander6 Tue, 09/13/2022 - 11:59

In This Story

Sapna Batheja, PhD, RDN, LDN

Why Front-Loading Calories May Not Help You Lose Weight.

Topics

Nutrition

Nutrition Faculty

Weight Control

Nutrition and Weight Management

CHHS in the Media

College of Health and Human Services Department of Nutrition and Food Studies

Wide Open eats: Health Administration Alumna Brianna Graham writes about fatphobia and the evolution of the ideal body type.

eander6 — Wed, 19 Jan 2022 18:13:36 +0000

Wide Open eats: Health Administration Alumna Brianna Graham writes about fatphobia and the evolution of the ideal body type. eander6 Wed, 01/19/2022 - 13:13

Fatphobia & Its Racist Past.

Topics

Weight Control

CHHS Alumni

CHHS in the Media

Health Administration

HAP Alumni

College of Health and Human Services Department of Health Administration and Policy

CPH Upward

San Francisco Chronicle: Picks up the Washington Post story in which Dr. Larry Cheskin comments on gaining weight over the holidays.

eander6 — Tue, 14 Dec 2021 14:57:22 +0000

San Francisco Chronicle: Picks up the Washington Post story in which Dr. Larry Cheskin comments on gaining weight over the holidays. eander6 Tue, 12/14/2021 - 09:57

In This Story

Lawrence J. Cheskin, MD

A holiday gift that no one wants: More weight.

Topics

College of Health and Human Services Department of Global and Community Health

Northern Virginia Magazine: Dr. Elisabeth de Jonge comments on a diet tailored to your circadian rhythms.

eander6 — Thu, 11 Nov 2021 18:54:28 +0000

Northern Virginia Magazine: Dr. Elisabeth de Jonge comments on a diet tailored to your circadian rhythms. eander6 Thu, 11/11/2021 - 13:54

In This Story

Lilian de Jonge, PhD

The Time You Eat at Could Make You Gain Weight, This Mason Professor Says.

Topics

College of Health and Human Services Department of Nutrition and Food Studies

Weight Control

Food as medicine: Six insights from a 911���� nutrition expert

In This Story

Key Takeaways

Topics

911���� leads phase 2 clinical trial for pill to help maintain weight loss after GLP-1s

Related Stories

In This Story

Topics

South Florida Reporter: Dr. Sapna Batheja comments on the limitations of research in an article on the weight loss method of front-loading calories

In This Story

Topics

Wide Open eats: Health Administration Alumna Brianna Graham writes about fatphobia and the evolution of the ideal body type.

Topics

San Francisco Chronicle: Picks up the Washington Post story in which Dr. Larry Cheskin comments on gaining weight over the holidays.

In This Story

Topics

Northern Virginia Magazine: Dr. Elisabeth de Jonge comments on a diet tailored to your circadian rhythms.

In This Story

Topics

Food as medicine: Six insights from a 911�� nutrition expert

911�� leads phase 2 clinical trial for pill to help maintain weight loss after GLP-1s